Schmidt TJ, et al. - Authors assessed the compliance with hyperlipidaemia screening guidelines for cardiovascular disease prevention in rheumatoid arthritis (RA) vs the general population. Findings suggested poor compliance with general population guidelines for hyperlipidaemia screening in RA. In spite of a higher risk of cardiovascular diseases, this did not differ from the general population. Per patient mean (S.D.) compliance rate was 47.2% for RA and 46.6% for controls.